Role of Endothelial Progenitors in Hematopoietic Stem Cell Expansion
Role of Endothelial Progenitors in Hematopoietic Stem Cell Expansion
批准号:
7670373
负责人:
Mervin C. YODER
金额:
$22.99万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdultAgeAgingAnimalsBloodBlood VesselsBlood capillariesBlood specimenCD34 geneCell Surface ProteinsCell TransplantationCellsClinicalCoculture TechniquesCommitDataData AnalysesDevelopmentEndothelial CellsEndotheliumEngraftmentFrequenciesGoalsGrowthGrowth FactorHematopoieticHematopoietic SystemHematopoietic stem cellsHumanIn VitroInjection of therapeutic agentKidneyLeadMacaca mulattaMarrowMesenchymal Stem CellsMethodsModelingMorphologyNumbersPTPRC genePatientsPopulationPre-Clinical ModelPrincipal InvestigatorProceduresPropertyRoleSCID MiceSamplingSecondary toSourceStagingStem cellsStructureTelomeraseTestingTransplantationUmbilical Cord BloodUmbilical cord structureVascular Endotheliumagedcapillarycell growthcytokinedayfeedingfetalimprovedin uteronovelperipheral bloodprogenitorprograms
中文摘要
人脐血已被证明是临床移植的一种有效的造血干细胞来源。在成人患者中更广泛地使用这种材料的一个主要限制是,脐带血样本中的HSC数量可能不足以移植到成人患者身上,特别是没有血缘关系和不匹配的受者。脐带血中扩增HSC的方法的确定将是该领域的重大进展。我们最近发现了一系列内皮祖细胞(EPC),它们在血液中循环,但也包括人类和猕猴血管内皮细胞内膜的一部分。与造血系统相似,内皮祖细胞是以一种层级结构组织起来的,在这种层级中,增殖能力最强的前体细胞会产生大量增殖能力较弱的后代,但更多的证据表明成熟的内皮细胞没有增殖能力。在初步研究中,与成人血液相比,人脐血中的EPC含量有所增加。我们假设EPC的频率和分布在个体发育过程中发生变化,导致循环细胞和血管内EPC的数量随着年龄的增长而减少,与端粒酶活性相关的增殖能力丧失。在其他初步数据中,我们已经确定与人骨髓干细胞共培养的脐带血EPC与新鲜分离的骨髓HSC相比,HSC>;260倍。我们现在假设,具有最高增殖潜力的EPC比具有较低增殖潜力的EPC更能促进HSC的扩增。为了验证这些假设,我们提出了以下目标:具体目标1.确定人脐血内皮祖细胞在体外扩增人脐血HSC中的作用。人脐血将与EPC共培养吗?宫内注射恒河猴胎儿宿主后生长因子和再繁殖能力的比较。特定目的2.测定血液和血管内皮细胞来源的EPC在恒河猴个体发育过程中的频率和增殖能力。对恒河猴受试者从胎儿到老年人的主动脉内皮细胞和外周血进行EPC含量、增殖能力和端粒酶活性的检测。我们假设EPC的增殖潜力随着年龄的增长而下降,恒河猴模型允许我们有机会对整个物种个体发育过程中的血管和血液进行采样。具体目的3.确定胎儿和成人血管来源的EPC在胎儿脐带血和成人骨髓HSC体外扩增中的作用。我们假设胎儿EPC将比成人HSC更适宜于胎儿HSC的扩增,但成人HSC在胎儿EPC上的扩增将比成人EPC更好。
英文摘要
Human umbilical cord blood has been demonstrated to be an effective source of hematopoietic stem cells (HSC) for clinical transplantation. A major limitation to the more widespread use of this material for adult patients is that the number of HSC in a cord blood sample may be insufficient to engraft in adult patients, particularly unrelated and mismatched recipients. Determination of a method to expand HSC in cord blood would be a major advance in the field. We have recently identified a hierarchy of endothelial progenitor cells (EPC) that circulate in the blood, but also comprise a portion of the endothelial cell intima in human and rhesus macaque blood vessels. Similar to the hematopoietic system, EPC are organized in a hierarchy in which the most proliferative progenitors give rise to numerous progeny with less proliferative potential but greater evidence of maturation with the most mature endothelial cells displaying no proliferative potential. In preliminary studies, human umbilical cord blood was enriched in EPC compared to adult blood. We hypothesize that the frequency and distribution of EPC changes during ontogeny such that the number of circulating cells and EPC residing in vessels decline with age and there is loss of proliferative potential that correlates with telomerase activity. In other preliminary data, we have determined that cord blood EPC co- cultured with human marrow stem cells expands HSC >260 fold compared to freshly isolated marrow HSC. We now hypothesize that EPCwith the highest proliferative potential will better promote HSC expansion than EPC with lower proliferative potential. To test these hypotheses, we proposed the following aims: Specific Aim 1. Determine the role of human cord blood EPC in expanding human cord blood HSC ex vivo. Human cord blood will be co-cultured with EPC ? growth factors and the repopulating ability compared following injection into rhesus fetal hosts in utero. Specific Aim 2. Determine the frequency and proliferative potential of EPC derived from blood and vascular endothelium throughout rhesus ontogeny. Aortic endothelial cells and peripheral blood of rhesus subjects from fetal to aged adults will be examined for EPC content, proliferative potential, and telomerase activity. We hypothesize that EPC proliferative potential declines with age and the rhesus model permits us an opportunity to sample vessels and blood throughout the entire species ontogeny. Specific Aim 3. Determine the role of EPC derived from fetal versus adult blood vessels in the in vitro expansion of fetal rhesus cord blood and adult marrow HSC. We hypothesize that the fetal EPC will more optimally expand fetal than adult HSC but adult HSC will be better expanded on fetal than adult EPC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lymphopoietic development in the extra-embryonic yolk sac
-
批准号:7994151
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2008
-
负责人:Mervin C. YODER
-
依托单位:
Lymphopoietic development in the extra-embryonic yolk sac
-
批准号:7751826
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2008
-
负责人:Mervin C. YODER
-
依托单位:
Lymphopoietic development in the extra-embryonic yolk sac
-
批准号:7565153
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2008
-
负责人:Mervin C. YODER
-
依托单位:
Lymphopoietic development in the extra-embryonic yolk sac
-
批准号:8389561
-
项目类别:
-
资助金额:$33.26万
-
财政年份:2008
-
负责人:Mervin C. YODER
-
依托单位:
Lymphopoietic development in the extra-embryonic yolk sac
-
批准号:8197030
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2008
-
负责人:Mervin C. YODER
-
依托单位:
Cord Blood Stem Cell Expansion Ex Vivo With Endothelial Progenitor Cells
-
批准号:6993884
-
项目类别:
-
资助金额:$10.7万
-
财政年份:2005
-
负责人:Mervin C. YODER
-
依托单位:
Role of Endothelial Progenitors in Hematopoietic Stem Cell Expansion
-
批准号:7081088
-
项目类别:
-
资助金额:$23.08万
-
财政年份:2005
-
负责人:Mervin C. YODER
-
依托单位:
Core B- Cell and Vector Core
-
批准号:7081096
-
项目类别:
-
资助金额:$42.01万
-
财政年份:2005
-
负责人:Mervin C. YODER
-
依托单位:
ENDOTHELIAL CELL ROLE IN YOLK SAC STEM CELL DEVELOPMENT
-
批准号:6184767
-
项目类别:
-
资助金额:$25.31万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
Endothelial Cell Role in Yolk Sac Stem Cell Development
-
批准号:7391197
-
项目类别:
-
资助金额:$40.15万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
Endothelial Cell Role in Yolk Sac Stem Cell Development
-
批准号:7045963
-
项目类别:
-
资助金额:$43.15万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
ENDOTHELIAL CELL ROLE IN YOLK SAC STEM CELL DEVELOPMENT
-
批准号:6390451
-
项目类别:
-
资助金额:$31.85万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
Endothelial Cell Role in Yolk Sac Stem Cell Development
-
批准号:6866599
-
项目类别:
-
资助金额:$43.03万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
Endothelial Cell Role in Yolk Sac Stem Cell Development
-
批准号:6990128
-
项目类别:
-
资助金额:$1.42万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
ENDOTHELIAL CELL ROLE IN YOLK SAC STEM CELL DEVELOPMENT
-
批准号:6537643
-
项目类别:
-
资助金额:$35.77万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
ENDOTHELIAL CELL ROLE IN YOLK SAC STEM CELL DEVELOPMENT
-
批准号:2889751
-
项目类别:
-
资助金额:$26.04万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
Endothelial Cell Role in Yolk Sac Stem Cell Development
-
批准号:7218653
-
项目类别:
-
资助金额:$43.04万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
Endothelial Cell Role in Yolk Sac Stem Cell Development
-
批准号:6786876
-
项目类别:
-
资助金额:$37.63万
-
财政年份:1999
-
负责人:Mervin C. YODER
-
依托单位:
ANALYSIS OF STROMAL CELL EFFECTS ON FETAL HEMATOPOIESIS
-
批准号:2213351
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1993
-
负责人:Mervin C. YODER
-
依托单位:
ANALYSIS OF STROMAL CELL EFFECTS ON FETAL HEMATOPOIESIS
-
批准号:3057172
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1992
-
负责人:Mervin C. YODER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: